Literature DB >> 16425131

Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis.

Rosemarijn Renckens1, Joris J T H Roelofs, Sandrine Florquin, Tom van der Poll.   

Abstract

BACKGROUND: Urokinase-type plasminogen activator receptor (uPAR) is expressed on many different cells, including leukocytes. uPAR has been implicated to play a role in neutrophil migration to sites of inflammation.
METHODS: To determine the role that uPAR plays in neutrophil recruitment in response to bacterial products or intact bacteria, uPAR gene-deficient (uPAR(-/-)) and wild-type (wt) mice were injected intraperitoneally with either Escherichia coli or lipopolysaccharide (LPS) derived from this bacterium.
RESULTS: uPAR(-/-) mice demonstrated a decreased LPS-induced neutrophil migration into peritoneal lavage fluid, whereas the chemokine and cytokine response was unaltered. In contrast, during E. coli-induced peritonitis, uPAR(-/-) mice had a normal neutrophil migration into the primary site of infection. The unaltered neutrophil trafficking in uPAR(-/-) mice during bacterial infection was corroborated by histological assessment of liver and lung tissue and myeloperoxidase levels in tissue homogenates. uPAR(-/-) mice displayed slightly but significantly lower bacterial loads in the peritoneal cavity, together with a decreased dissemination to the circulation early during the infection.
CONCLUSION: These data suggest that uPAR, in part, mediates neutrophil migration into the peritoneal cavity on local instillation of LPS but that this function of uPAR can be compensated for during peritonitis caused by intact E. coli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425131     DOI: 10.1086/499601

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  TLR4 inhibition impairs bacterial clearance in a therapeutic setting in murine abdominal sepsis.

Authors:  Miriam H P van Lieshout; Tom van der Poll; Cornelis van't Veer
Journal:  Inflamm Res       Date:  2014-08-15       Impact factor: 4.575

Review 2.  Urokinase and its receptors in chronic kidney disease.

Authors:  Guoqiang Zhang; Allison A Eddy
Journal:  Front Biosci       Date:  2008-05-01

3.  Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.

Authors:  Unni K Samavedam; Nina Mitschker; Anika Kasprick; Katja Bieber; Enno Schmidt; Tamás Laskay; Andreas Recke; S Goletz; Gestur Vidarsson; Franziska S Schulze; Mikko Armbrust; Katharina Schulze Dieckhoff; Hendri H Pas; Marcel F Jonkman; Kathrin Kalies; Detlef Zillikens; Yask Gupta; Saleh M Ibrahim; Ralf J Ludwig
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

4.  TLR4 Response to LPS Is Reinforced by Urokinase Receptor.

Authors:  Yulia Kiyan; Sergey Tkachuk; Song Rong; Anna Gorrasi; Pia Ragno; Inna Dumler; Hermann Haller; Nelli Shushakova
Journal:  Front Immunol       Date:  2020-12-09       Impact factor: 7.561

5.  The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi.

Authors:  Joppe W R Hovius; Maarten F Bijlsma; Gerritje J W van der Windt; W Joost Wiersinga; Bastiaan J D Boukens; Jeroen Coumou; Anneke Oei; Regina de Beer; Alex F de Vos; Cornelis van 't Veer; Alje P van Dam; Penghua Wang; Erol Fikrig; Marcel M Levi; Joris J T H Roelofs; Tom van der Poll
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

6.  The effect of colostrum intake on blood plasma proteome profile in newborn lambs: low abundance proteins.

Authors:  Lorenzo Enrique Hernández-Castellano; André Martinho Almeida; Miguel Ventosa; Ana Varela Coelho; Noemí Castro; Anastasio Argüello
Journal:  BMC Vet Res       Date:  2014-04-05       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.